Loading...
Two-dose emtricitabine/tenofovir alafenamide plus bictegravir prophylaxis protects macaques against SHIV infection
OBJECTIVES: Current prophylaxis options for people at risk for HIV infection include two US FDA-approved daily pre-exposure prophylaxis (PrEP) regimens and guidelines for a 2-1-1 event-driven course specifically for men who have sex with men. Despite this, PrEP use rates remain suboptimal, and addit...
Na minha lista:
| Udgivet i: | J Antimicrob Chemother |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7879143/ https://ncbi.nlm.nih.gov/pubmed/33202006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa476 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|